Diabetes: Significance of HbA1c Testing
An inaccurate test report may lead an unsuspecting clinician to make wrong patient care decisions. How can clinical laboratories avoid incorrect HbA1c results?
We are thrilled to announce our new partnership with bioMérieux Philippines Corporation (bioMérieux), a global leader in the field of in vitro diagnostics since 1963. For over 60 years, they have been innovating to drive progress in pathogen detection and identification.
Everlife-Lifeline is honored to be their newly appointed distributor in the Philippines. Our reputation for delivering quality healthcare solutions aligns seamlessly with bioMérieux's mission to provide accurate and timely diagnostic tools, particularly in the critical field of pathogen detection.
This partnership marks a significant milestone in the realm of healthcare, promising to elevate diagnostics and healthcare standards in the Philippines. As this partnership unfolds, the healthcare community in the Philippines can anticipate a wave of innovative diagnostic solutions that will redefine the way diseases are detected and managed, ultimately bringing us one step closer to a healthier and safer future.